Nantahala Capital Management, LLC Nautilus Biotechnology, Inc. Transaction History

Nantahala Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$1.55 - $2.47 $566,514 - $902,767	-365,493 Reduced 55.77%	289,845 $521,000
Q3 2022 Nov 10, 2022	SELL	$1.96 - $3.13 $253,741 - $405,209	-129,460 Reduced 16.5%	655,338 $1.39 Million
Q2 2022 Aug 15, 2022	SELL	$2.64 - $4.84 $287,134 - $526,412	-108,763 Reduced 12.17%	784,798 $2.11 Million
Q1 2022 May 13, 2022	SELL	$3.5 - $5.3 $477,088 - $722,448	-136,311 Reduced 13.24%	893,561 $3.88 Million
Q4 2021 Feb 14, 2022	SELL	$4.45 - $6.21 $64,057 - $89,392	-14,395 Reduced 1.38%	1,029,872 $5.34 Million
Q3 2021 Nov 15, 2021	SELL	$6.14 - $10.1 $899,774 - $1.48 Million	-146,543 Reduced 12.31%	1,044,267 $6.41 Million
Q2 2021 Aug 16, 2021	BUY	$9.04 - $14.19 $10.8 Million - $16.9 Million	1,190,810 New	1,190,810 $12 Million

63.8M

2.9K

500

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $328M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.